Clinical trial
Development of a Wearable Ultrasound Imaging System and Its Application in Intraoperative Cardiac Monitoring and Cardiopulmonary Monitoring in Critical Care
NCT07891052 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of a Wearable Ultrasound Imaging System and Its Application in Intraoperative Cardiac Monitoring and Cardiopulmonary Monitoring in Critical Care
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 30, 2026
- Completion date
- December 31, 2028
- Enrollment
- 600 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
Arms
As registered; 1 arm.
-
Wearable Ultrasound Monitoring
All participants will undergo cardiac monitoring using a wearable ultrasound imaging system in addition to conventional bedside echocardiography. Wearable ultrasound assessments will generally be performed hourly under stable clinical conditions and additionally when significant circulatory changes occur. Conventional bedside echocardiography will be performed daily for comparison. A subgroup of 400 participants will also undergo integrated monitoring combining wearable ultrasound with electrocardiography, blood pressure, and oxygen saturation measurements.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Agreement in Left Ventricular Ejection Fraction Measurements
Agreement between left ventricular ejection fraction (LVEF) measurements obtained using wearable ultrasound and conventional bedside echocardiography will be assessed using the intraclass correlation coefficient (ICC). Paired measurements will be used to evaluate the consistency of the two methods.
Lead sponsor's other trials
China National Center for Cardiovascular Diseases, most recent start first.
+264 more trials See the organization page
Similar trials
Same condition (Cardiovascular Diseases) and phase, most recent start first.
+2,119 more trials See the condition page